INKT Earnings

Quarterly EPS
$-0.62
Q4 2024
$-0.70
Q1 2025
$-1.06
Q2 2025
$-0.65
Q3 2025
$-0.55
Q4 2025
$-0.57
Q1 2026
$-0.62
Q2 2026
$-0.50
Q3 2026
Latest Revenue200.0K
Latest Net Income-2552283
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.50200.0K-2552283—+23.1%
Q2 2026-$0.620-3128201—+41.5%
Q1 2026-$0.570-2742368—+18.6%
Q4 2025-$0.550-2602103—+11.3%
Q3 2025-$0.650-2887709—-41.3%
Q2 2025-$1.060-4237751—-45.2%
Q1 2025-$0.700-2766697—+36.4%
Q4 2024-$0.620-2463104—+60.8%
Q3 2024-$0.460-1806597——
Q2 2024-$0.730-2701806——
Q1 2024-$1.100-3813295——
Q4 2023-$1.580-5458597——
MiNK Therapeutics (INKT) — Earnings